Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses

Gene Therapy

Volumn 5, Issue 8, 1998, Pages 1079-1087

  DeBruyne, L A ^a   Li, K ^a   Chan, S Y ^a   Qin, L ^a   Bishop, D K ^a   Bromberg, J S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Gene transfer; Immunotherapy; Transplantation; Viral interleukin 10 (vIL 10)

Indexed keywords

CATION; COLLAGEN; CYTOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; LIPID; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EDEMA; FEMALE; GENE TRANSFER; GRAFT SURVIVAL; HEART GRAFT; HELPER CELL; HISTOCOMPATIBILITY; HISTOLOGY; HUMORAL IMMUNITY; IMMUNOGENETICS; INTERSTITIUM; MOUSE; MUSCLE CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; SPLEEN; VIRUS;

ANIMALIA;

EID: 0031667550     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300694     Document Type: Article

References (51)

1. Qin L et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model: immunosuppression with TGF-βl or vIL-10. Transplantation 1995; 59: 809-816.
2. Qin L et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac ailograft survival. J Immunol 1996; 156: 2316-2323.
3. Bromberg JS, DeBruyne LA, Qin L. Interactions between the immune system and gene therapy vectors. Bidirectional regulation of response and expression. Adv Immunol 1998; 69: 353-408.
4. Knechtle SJ, Zhai Y, Fechner J. Gene therapy in transplantation. Transplant Immunol 1996; 4: 257-264.
5. Moore KW et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230-1234.
6. Moore KW et al. Interleukin-10. Annu Rev Immunol 1993; 11: 165-190.
7. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991; 12: A49-53.
8. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science 1993; 260: 496-497.
9. Seder RA, Gazzinelli R, Sher A, Paul WE. Interleukin 12 acts directly on CD4- T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90: 10188-10192.
10. de Waal Malefyt R et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-1220.
11. Fiorentino DF et al. 1991. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822.
12. de Waal Malefyt R et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915-924.
13. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 1993; 151: 2390-2398.
14. Ding L et al. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224-1234.
15. Willems F et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-l expression on human monocytes. Eur J Immunol 1994; 24: 1007-1009.
16. Chen WF, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528-534.
17. Rousset F et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890-1893.
18. Thompson-Snipes L et al. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991; 173: 507-510.
19. Hsu D-H et al. Expression of interleukin-10 activity by EpsteinBarr virus protein BCRF1. Science 1990; 250: 830-832.
20. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994; 56: 1-26.
21. Wogensen L, Lee MS, Sarvetnick N. Production of interleukin 10 fay islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp Med 1994; 179: 1379-1384.
22. Suzuki T et al. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med 1995; 182: 477-486.
23. Qin L et al. Gene transfer for transplantation: prolongation of allograft survival with transforming growth factor-βl. Ann Surg 1994; 220: 508-519.
24. Qin L, Ding Y, Bromberg JS. Gene transfer of transforming growth factor-βl prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther 1996; 7: 1981-1988.
25. Stephan DJ et al. A new cationic liposome-DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996; 7: 1803-1812.
26. Bishop DK, Shelby J, Eichwald EJ. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Transplantation 1992; 53: 849-857.
27. Reitamo S et al. Interleukin 10 up-regulates elastin gene expression in vivo and in vitro at the transcription level. Biochem J 1994; 302: 331-333.
28. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249: 1285-1288.
29. Ardehali A et al. Direct gene transfer into donor hearts at the time of harvest. J Thor Cardia Surg 1995; 109: 716-719.
30. Fyfe Al et al. Biologic modification of the immune response in mouse cardiac isografts using gene transfer. J Heart Lung Transplant 1995; 14: S165-170.
31. Gojo S et al. Ex vivo gene transfer to transplanted heart grafts using adenoviral vector. Transplant Proc 1996; 28: 1818-1819.
32. Lee J et al. Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. J Thor Cardia Surg 1996; 111: 246-252.
33. Shiraishi M et al. Adenovirus-mediated gene transfer using ex vivo perfusion of the heart graft. Surg Today 1996; 26: 624-628.
34. Donahue JK et al. Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci USA 1997; 94: 4664-668.
35. Wang J, Ma Y; Knechtle SJ. Adenovirus-mediated gene transfer into rat cardiac allografts. Transplantation 1996, 61: 1726-1729.
36. Qin L et al. Adenovirus-mediated gene transfer of viral interleukin 10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 1997; 8. 1365-1374.
37. Wogensen L, Huang X, Sarvetnick N. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 1993; 178: 175-185.
38. Lee MS et al. Pancreatic islet production of murine interleukin10 does not inhibit immune-mediated tissue destruction. J Clin Invest 1994; 93: 1332-1338.
39. Benhamou PY et al. Decreased alloreactivity to human islets secreting recombinant viral interleukin 10. Transplantation 1996; 62: 1306-1312.
40. Drazan KE et al. Transduction of hepatic allografts achieves local levels of viral IL-10 which suppress alloreactivity in vitro. J Surg Res 1995; 59: 219-223.
41. Holschneider CH et al. Endogenous versus exogenous IL-10 in postoperative intraperitoneal adhesion formation in a murine model. J Surg Res 1997; 70: 138-143.
42. Pajkrt D. Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood 1997; 89: 2701-2705.
43. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990; 63: 245-247.
44. Nilsen-Hamilton M. Transforming growth factor-β and its actions on cellular growth and differentiation. Curr Top Develop Biol 1990; 24: 95-136.
45. Isaka Y et al. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into rat kidney. J Clin Invest 1993; 92: 2597-2601.
46. Philip R et al. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol Cell Biol 1994; 14: 2411-2418.
47. Corry RJ, Winn HS, Russell PS. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343-350.
48. Bacchetta R et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994; 179: 493-502.
49. Bishop DK, Orosz CG. Limiting dilution analysis for alloreactive, TCGF-secreting T cells: LDA methods that discriminate between unstimulated precursor T cells and in vivo alloactivated T cells. Transplantation 1989; 47: 671-677.
50. Orosz CG, Horstemeyer B, Zinn NE, Bishop DK. Development and evaluation of an LDA technique that can discriminate in vivo alloactivated CTL from their naive CTL precursors. Transplantation 1989; 47- 189-194.
51. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614-1619.